Logo-hpp
2023: Two-year Impact Factor: 2.4
Scopus Journal Metrics
CiteScore (2023):7.1
  		Platinum
Open Access
Health Promot Perspect. 2023;13(2): 140-146. doi: 10.34172/hpp.2023.17
PMID: 37600544        PMCID: PMC10439450

Original Article

Use and outcomes of antihypertensive medication treatment in the US hypertensive population: A gender comparison

Shakir Ullah 1 ORCID, Shahbaz Khan 2 ORCID, Shahrzad Bazargan-Hejazi 1,3 * ORCID, Ernesto Ramirez 1, Senait Teklehaimanot 1, Sara Diab 4, Maria Bangash 5, Magda Shaheen 1,3

Cited by CrossRef: 2

1- Sagara K, Goto K, Maeda M, Murata F, Fukuda H. Medication adherence and associated factors in newly diagnosed hypertensive patients in Japan: the LIFE study. 2024;42(4):718 [Crossref]
2- Stanovska L, Krynytska I. ASSOCIATION OF ACHIEVEMENT/FAILURE OF THE TARGET LEVEL OF BLOOD PRESSURE AND ADHERENCE TO ANTIHYPERTENSIVE TREATMENT IN OUTPATIENTS WITH ISOLATED ARTERIAL HYPERTENSION AND IN COMBINATION WITH CARDIOVASCULAR COMORBIDITY. VPBM. 2024;1(1):253 [Crossref]

Indexing and Abstracting

2-year Impact Factor: 2.4

SCOPUS CiteScore: 7.1

  Scimago Journal & Country Rank 

 

 


     Linked in Profile

   Academia Profile

Officially associated with The Iranian Health Education & Promotion Association  
Publication Advantages

Free of charge publication

Open access 

Fast and constructive peer review

Easy and fast online submission